Search Header Logo

Test part II NM

Authored by siwaporn thamcharoenvipas

Health Sciences

University

Used 4+ times

Test part II NM
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

10 questions

Show all answers

1.

MULTIPLE SELECT QUESTION

30 sec • 10 pts

Media Image

สารตัวไหนบ้างที่เป็น Nonspecific tumor imaging

Ga-67

Tl-201

Tc-99m sestamibi

In-111 pentetreotide

2.

MULTIPLE CHOICE QUESTION

30 sec • 10 pts

Media Image

Limitation of Tl-201

Short half-life

High-energy photon

low administered activity

ถูกทุกข้อ

3.

MULTIPLE CHOICE QUESTION

45 sec • 15 pts

Media Image

ข้อใดถูก

Ga-67 more sensitive for lymphoma than F-18 FDG

Tl-201 localizes in viable neoplasm

Tc-99m MIBI sensitive for heart tumor

ถูกทุกข้อ

4.

MULTIPLE CHOICE QUESTION

45 sec • 10 pts

Media Image

เกี่ยวกับ Somatostatin receptor imaging

สารที่ใช้ เช่น Ga-68 PET/CT, In-111 pentetreotide

Uptake In-111 = candidate for octreotide therapy

Ga-68 recommended over In-111

ถูกทุกข้อ

5.

MULTIPLE CHOICE QUESTION

45 sec • 15 pts

Media Image

Treatment of hepatoma and liver metastasis ข้อใดถูก

สารที่ใช้รักษาคือ Y-90 microsphere

ฉีดเข้าทาง hepatic artery

Before Y-90 microsphere treatment ต้องถาม Tc-99m MAA ก่อน

ถูกทุกข้อ

6.

MULTIPLE SELECT QUESTION

45 sec • 20 pts

Media Image

ข้อใดถูกเกี่ยวกับ infection and inflammation scan

Ga-67 ใช้ monitor treatment response in malignant otitis externa

Hot spot of WBC scan in osteomyelitis of spine

ควรทำ WBC scan คู่กับ Sulfur colloid scan

FDG PET/CT = High specificity but low sensitivity

7.

MULTIPLE CHOICE QUESTION

30 sec • 10 pts

Media Image

Advantage of Ga-67 for infection and inflammation

Long HF

Four photopeak

Increased uptake 2-3 weeks at post operative sited after Sx

เป็น disadvantage ทั้งหมด

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Microsoft

Continue with Microsoft

or continue with

Facebook

Facebook

Apple

Apple

Others

Others

Already have an account?